Dec 29 (Reuters) - Aptose Biosciences Inc APS.TO :
* Aptose Biosciences provides update on apto-253 development
* Aptose Biosciences Inc - has successfully manufactured multiple batches of a new drug product formulation for APTO-253
* Aptose Biosciences - will have to repeat production of fourth batch, a 40l batch that was intended clinical supply
* Aptose Biosciences - will have to repeat production of fourth batch because of a correctable engineering design incompatibility during filling process
* Aptose - "while we have encountered delays in manufacturing activities, we also have continued mechanistic and pharmacokinetic testing of APTO-253"
* Aptose Biosciences Inc - also continue to advance development of CG'806
* Aptose -expects batch records,release specifications from such new batch, alongwith stability,sterility data,be provided to FDA during q1 2017
* Aptose Biosciences provides update on apto-253 development Source text for Eikon: ID:nGNXNNRNQa Further company coverage: APS.TO